| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/31/2002 | WO2000059941A9 Purposeful movement of human migratory cells away from an agent source |
| 01/31/2002 | WO2000056900A3 Promoter sequences derived from fusarium venenatum and uses thereof |
| 01/31/2002 | WO2000047219A3 Methods and reagents for treating glucose metabolic disorders |
| 01/31/2002 | US20020013957 Genetically engineering swine embryos; culture swine embryos, translocate nucleus to another swine embryo, activate oocyte, monitor embryo development |
| 01/31/2002 | US20020013455 Isolation and identification of novel polymerases |
| 01/31/2002 | US20020013285 Nucleosome-based anti-tumor compositions |
| 01/31/2002 | US20020013283 Bombarding a plant or animal cell with a microparticle of a composite of a metal support, a dendritic polymer and the genetic material; high density; efficiency; delivering higher quantities of genetic materials with less damage |
| 01/31/2002 | US20020012998 Gene transfer composition; for use in the transfection of mammalian cells |
| 01/31/2002 | US20020012997 Transducing cell; incubate cells with nucleotide sequences, insert cells into mammals, monitor mammals for phenotypic adjustment |
| 01/31/2002 | US20020012996 Mutating genes; mix cell and vector, transform mammalian cells, recover cells |
| 01/31/2002 | US20020012995 Negative-sense RNA virus vector for nerve cell |
| 01/31/2002 | US20020012994 Improved embryogenesis process for initiation and maturation |
| 01/31/2002 | US20020012993 Improved immortalized human skin cell lines and novel serum-free medium useful for the production thereof |
| 01/31/2002 | US20020012992 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 01/31/2002 | US20020012991 Nutrient broth; for use in the generation of monoclonal antibodies and preferential particles; for use in maintenance of cell viability |
| 01/31/2002 | US20020012984 Genetic engineering |
| 01/31/2002 | US20020012979 Biosynthesis; using isomerization enzyme |
| 01/31/2002 | US20020012976 Plant extract |
| 01/31/2002 | US20020012966 18 Human secreted proteins |
| 01/31/2002 | US20020012965 Nucleotide sequences coding prfeerential polypeptides for use in the diagnosis and treatment of brain disorders and injury |
| 01/31/2002 | US20020012962 Nucleotide sequences coding fusion protein for use in the treatment of osteoporosis, cancers, and cachexia |
| 01/31/2002 | US20020012954 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 01/31/2002 | US20020012921 Identification of genetic components of drug response |
| 01/31/2002 | US20020012905 Generating profile of preferential chemical intermediates; incubate liver stem cells with chemical intermediate, monitor cells, detect adjustments in gene expression, classify respones to chemical intermediate |
| 01/31/2002 | US20020012903 Separating neuronal pluripotent stem cells from mixed sample of cells; transform cells, express marker, recover cells expressing marker |
| 01/31/2002 | US20020012901 Thawing cryogenically preserved cells; heat the cells, transfer cells to second container, monitor cells |
| 01/31/2002 | US20020012705 Polymer constructs |
| 01/31/2002 | US20020012696 In gene therapy and in in vitro and in vivo transfection |
| 01/31/2002 | US20020012669 For detecting a genetic abnormality, cancer |
| 01/31/2002 | US20020012668 Used in diagnostics, detection of the bacteria Salmonella.typhi or in the production of vaccines for typhoid fever |
| 01/31/2002 | US20020012667 Method for preventing allograft rejection |
| 01/31/2002 | US20020012664 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian CC-chemokine receptor 2, mammalian CC-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 01/31/2002 | US20020012661 Methods for introducing genes into mammalian subjects |
| 01/31/2002 | US20020012657 Method for in vitro preconditioning of myoblasts before transplantation |
| 01/31/2002 | US20020012655 Administering to or transplanting into least one cell or tissue obtained from cloned ungulate animal or embryo for therapy |
| 01/31/2002 | US20020012654 For production, expression and recovery of harvestable polypeptides, screening compounds for metabolic activity, studying enteric disease and for use in a bio-artificial liver device |
| 01/31/2002 | US20020012653 Has ability for self-regeneration in a culture medium |
| 01/31/2002 | DE10031179A1 Introducing active molecules into the nucleus of eukaryotic cells, useful for transfection and gene therapy, by applying controlled electrical pulse |
| 01/31/2002 | CA2429502A1 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 01/31/2002 | CA2418282A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | CA2418215A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | CA2418198A1 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | CA2417508A1 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 01/31/2002 | CA2417223A1 A novel member of the epha receptor family |
| 01/31/2002 | CA2417185A1 Multivalent target binding protein |
| 01/31/2002 | CA2416733A1 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | CA2416713A1 Novel siglecs and uses thereof |
| 01/31/2002 | CA2416701A1 Methods for the replacement, translocation and stacking of dna in eukaryotic genomes |
| 01/31/2002 | CA2416691A1 Proteases |
| 01/31/2002 | CA2416683A1 Dog melanin-concentrating hormone receptor |
| 01/31/2002 | CA2416682A1 Stem cell-like cells |
| 01/31/2002 | CA2416676A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | CA2416664A1 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | CA2416657A1 Fh-binding protein of streptococcus pneumoniae |
| 01/31/2002 | CA2416548A1 Artificial vascular grafts, and methods of producing and using same |
| 01/31/2002 | CA2416538A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | CA2416488A1 Codon-optimized papilloma virus sequences |
| 01/31/2002 | CA2416472A1 Nucleic acids compositions conferring dwarfing phenotype |
| 01/31/2002 | CA2416456A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/31/2002 | CA2416414A1 Human kinases |
| 01/31/2002 | CA2416404A1 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 01/31/2002 | CA2415077A1 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | CA2413851A1 Modified virus having an altered tropism |
| 01/31/2002 | CA2412626A1 Il-17 molecules and uses thereof |
| 01/31/2002 | CA2412544A1 Polypeptide delivery ii-2 |
| 01/30/2002 | EP1176207A2 Production of polyhydroxyalkanoate in plants |
| 01/30/2002 | EP1176206A2 Barley DEAD box protein HVD1 gene induced by salt stress |
| 01/30/2002 | EP1176203A1 Enzyme with improved NAD(H)-acceptance |
| 01/30/2002 | EP1176201A2 Platelet-specific chimeric immunoglobulin |
| 01/30/2002 | EP1176198A1 Novel fetal genes |
| 01/30/2002 | EP1176192A2 Helicobacter felis vaccine |
| 01/30/2002 | EP1176190A1 Cell culture medium, specially for in vitro fertilisation or for culture of follicles, males germ cells or embryos |
| 01/30/2002 | EP1176189A1 Stem cell-like cells |
| 01/30/2002 | EP1175513A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA |
| 01/30/2002 | EP1175504A1 Dna encoding the human vanilloid receptor vr1 |
| 01/30/2002 | EP1175503A1 49 human secreted proteins |
| 01/30/2002 | EP1175501A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 01/30/2002 | EP1175497A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 01/30/2002 | EP1175491A1 Recombinant protein uk114 and its use in therapy and diagnostics |
| 01/30/2002 | EP1175490A2 Tyrosine kinase substrate (tks) proteins |
| 01/30/2002 | EP1175487A2 Pancreatic progenitor cells, methods and uses related thereto |
| 01/30/2002 | EP1175446A1 Human antibodies that bind human il-12 and methods for producing |
| 01/30/2002 | EP1175444A1 Amino-terminal modified parathyroid hormone (pth) analogs |
| 01/30/2002 | EP1175442A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor |
| 01/30/2002 | EP1175440A1 48 human secreted proteins |
| 01/30/2002 | EP1175439A1 49 human secreted proteins |
| 01/30/2002 | EP1175438A1 62 human secreted proteins |
| 01/30/2002 | EP1175436A2 Transiently immortalized cells for use in gene therapy |
| 01/30/2002 | EP1175228A1 Gene therapy using tgf-beta |
| 01/30/2002 | EP1175227A1 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 01/30/2002 | EP1175223A2 Methods and compositions for modulating an immune response |
| 01/30/2002 | EP1175144A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 01/30/2002 | EP1045897B1 Enzyme catalyzed therapeutic agents |
| 01/30/2002 | EP0956009B1 Treatment of neurodegenerative conditions with nimesulide |
| 01/30/2002 | EP0904539A4 Inhibiting protein interactions |
| 01/30/2002 | EP0888373A4 Smooth muscle cell lim protein |
| 01/30/2002 | EP0668913B1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 01/30/2002 | EP0617736B1 Use of bacillus thuringiensis isolates for controlling pests in the family aphididae |
| 01/30/2002 | EP0596979B1 Recombinant plant viral nucleic acids |
| 01/30/2002 | EP0564502B1 Tissue sealant and growth factor containing compositions that promote accelerated wound healing |